Literature DB >> 27243896

Hematopoietic Stem Cells from Ts65Dn Mice Are Deficient in the Repair of DNA Double-Strand Breaks.

Yingying Wang1,2, Jianhui Chang2, Lijian Shao2, Wei Feng2, Yi Luo2, Marie Chow3, Wei Du2, Aimin Meng1, Daohong Zhou2.   

Abstract

Down syndrome (DS) is a genetic disorder caused by the presence of an extra partial or whole copy of chromosome 21. In addition to musculoskeletal and neurodevelopmental abnormalities, children with DS exhibit various hematologic disorders and have an increased risk of developing acute lymphoblastic leukemia and acute megakaryocytic leukemia. Using the Ts65Dn mouse model, we investigated bone marrow defects caused by trisomy for 132 orthologs of the genes on human chromosome 21. The results showed that, although the total bone marrow cellularity as well as the frequency of hematopoietic progenitor cells (HPCs) was comparable between Ts65Dn mice and their age-matched euploid wild-type (WT) control littermates, human chromosome 21 trisomy led to a significant reduction in hematopoietic stem cell (HSC) numbers and clonogenic function in Ts65Dn mice. We also found that spontaneous DNA double-strand breaks (DSBs) were significantly increased in HSCs from the Ts65Dn mice, which was correlated with the significant reduction in HSC clonogenic activity compared to those from WT controls. Moreover, analysis of the repair kinetics of radiation-induced DSBs revealed that HSCs from Ts65Dn mice were less proficient in DSB repair than the cells from WT controls. This deficiency was associated with a higher sensitivity of Ts65Dn HSCs to radiation-induced suppression of HSC clonogenic activity than that of euploid HSCs. These findings suggest that an additional copy of genes on human chromosome 21 may selectively impair the ability of HSCs to repair DSBs, which may contribute to DS-associated hematological abnormalities and malignancies.

Entities:  

Mesh:

Year:  2016        PMID: 27243896      PMCID: PMC4943077          DOI: 10.1667/RR14407.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  35 in total

Review 1.  DNA repair defects in stem cell function and aging.

Authors:  Youngji Park; Stanton L Gerson
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

2.  Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses.

Authors:  Kai Rothkamm; Markus Löbrich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

3.  Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.

Authors:  M Dördelmann; M Schrappe; A Reiter; M Zimmermann; N Graf; G Schott; F Lampert; J Harbott; C Niemeyer; J Ritter; W Dörffel; G Nessler; J Kühl; H Riehm
Journal:  Leukemia       Date:  1998-05       Impact factor: 11.528

4.  Normal formation and repair of gamma-radiation-induced single and double strand DNA breaks in Down syndrome fibroblasts.

Authors:  M E Steiner; W G Woods
Journal:  Mutat Res       Date:  1982-08       Impact factor: 2.433

5.  Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis.

Authors:  Mary Mohrin; Emer Bourke; David Alexander; Matthew R Warr; Keegan Barry-Holson; Michelle M Le Beau; Ciaran G Morrison; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2010-07-08       Impact factor: 24.633

6.  Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome.

Authors:  R J Siarey; J Stoll; S I Rapoport; Z Galdzicki
Journal:  Neuropharmacology       Date:  1997 Nov-Dec       Impact factor: 5.250

7.  Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.

Authors:  James A Whitlock; Harland N Sather; Paul Gaynon; Leslie L Robison; Robert J Wells; Michael Trigg; Nyla A Heerema; Smita Bhatia
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

8.  Decreased repair of x-ray induced DNA single-strand breaks in lymphocytes in Down's syndrome.

Authors:  K Athanasiou; E G Sideris; C Bartsocas
Journal:  Pediatr Res       Date:  1980-04       Impact factor: 3.756

9.  Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.

Authors:  Gina Kirsammer; Sarah Jilani; Hui Liu; Elizabeth Davis; Sandeep Gurbuxani; Michelle M Le Beau; John D Crispino
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

10.  The epigenetic origin of aneuploidy.

Authors:  Luis A Herrera; Diddier Prada; Marco A Andonegui; Alfonso Dueñas-González
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

View more
  4 in total

1.  Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome.

Authors:  Bradley Pawlikowski; Nicole Dalla Betta; Tiffany Elston; Darian A Williams; Bradley B Olwin
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

2.  A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21.

Authors:  Yasuhiro Kazuki; Feng J Gao; Yicong Li; Anna J Moyer; Benjamin Devenney; Kei Hiramatsu; Sachiko Miyagawa-Tomita; Satoshi Abe; Kanako Kazuki; Naoyo Kajitani; Narumi Uno; Shoko Takehara; Masato Takiguchi; Miho Yamakawa; Atsushi Hasegawa; Ritsuko Shimizu; Satoko Matsukura; Naohiro Noda; Narumi Ogonuki; Kimiko Inoue; Shogo Matoba; Atsuo Ogura; Liliana D Florea; Alena Savonenko; Meifang Xiao; Dan Wu; Denise As Batista; Junhua Yang; Zhaozhu Qiu; Nandini Singh; Joan T Richtsmeier; Takashi Takeuchi; Mitsuo Oshimura; Roger H Reeves
Journal:  Elife       Date:  2020-06-29       Impact factor: 8.140

Review 3.  Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.

Authors:  Laszlo Pecze; Elisa B Randi; Csaba Szabo
Journal:  Mol Med       Date:  2020-11-09       Impact factor: 6.354

Review 4.  Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.

Authors:  Carmen Martínez-Cué; Noemí Rueda
Journal:  Int J Mol Sci       Date:  2020-09-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.